Cardiovascular Research
GLP1 agonists and SGLT2 inhibitors in heart failure management
When someone with heart failure sees an SGLT2 inhibitor and a GLP-1 receptor agonist discussed in the same breath, it is easy to…
Evidence-based journalism for lifelong cardiovascular health.
Explore peer-reviewed reporting, clinical insights, and habit mechanics across focused areas of cardiovascular prevention.
When someone with heart failure sees an SGLT2 inhibitor and a GLP-1 receptor agonist discussed in the same breath, it is easy to…